Center Laboratories, Inc. (TPEX:4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
41.30
+0.35 (0.85%)
Feb 21, 2025, 1:30 PM CST
-11.56%
Market Cap 29.75B
Revenue (ttm) 1.57B
Net Income (ttm) -415.44M
Shares Out 720.42M
EPS (ttm) -0.60
PE Ratio n/a
Forward PE n/a
Dividend 1.50 (3.63%)
Ex-Dividend Date Aug 2, 2024
Volume 1,302,067
Average Volume 1,322,524
Open 41.00
Previous Close 40.95
Day's Range 41.00 - 41.45
52-Week Range 39.65 - 59.60
Beta 0.77
RSI 49.70
Earnings Date Mar 25, 2025

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising of antipyretic and analgesic, bronchodilator, anti-inflammatory preparations, anti-allergic agent, expectorant, narcotic antitussive and expectorant, gastrointestinal preparations, non-narcotic antitussive and expectorant, and other medicines. It also offers central nervous system medication consisting of cerebrovascular disease, dementia, depressi... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.